Search results

The Innovative Licensing and Access Pathway (ILAP) is a unique initiative which works with medicine developers early on to help get new medicines to patients faster.

Home What NICE does Digital health...

Tools for building or evaluating a medtech evidence base with NICE

Managed access allows people to access promising new treatments that would otherwise not be recommended because it is too uncertain whether the treatment is cost-effective.

Learn from NICE International, part of the UK's National Institute for Health and Care Excellence, about how to improve your nation's health and wellbeing

Our experts can offer advice and support in contextualising our guidelines, or helping you adapt our content to your country or local context.

We provide an advisory service for international health organisations, ministries and government agencies whose task is to improve evidence-based decision making in health and social care.

Membership details, terms of reference, future meeting dates and past meeting minutes for our 4 technology appraisal committees.

Day-to-day decision making is the responsibility of NICE's executive team.

Bisphosphonates for treating osteoporosis Patient decision aid What is osteoporosis and how can bisphosphonates help? Everyone's bones get weaker as...

Biographies and registered interests for members of the Technology Appraisal Committee A

Find individual child abuse and neglect recommendations quickly and links to full guideline.

Home Get involved Our committees NICE committee meetings...

Home What NICE does {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/"

With around 2 million healthtech products registered for UK use, differentiating your innovation from the competition is vital. A NICE recommendation helps you cut through the noise, demonstrate your product’s value and smooth your path to market.